TheraRadar
← Back
Data updated: Mar 29, 2026

PHATHOM

Infectious DiseaseCardiovascularDermatology
Pharma

PHATHOM is a pharmaceutical company focused on Infectious Disease, Cardiovascular, Dermatology. Key products include VOQUEZNA TRIPLE PAK.

2022
Since
3
Drugs
-
Trials
11
Approved (2yr)

Key Drugs

VOQUEZNA TRIPLE PAK
amoxicillin
5 indications · 2022
VOQUEZNA
vonoprazan fumarate
H+, K+-ATPase 4 indications · 2023
VOQUEZNA DUAL PAK
amoxicillin
H+, K+-ATPase 1 indications · 2022

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

VOQUEZNA 2025-11-06
Labeling
VOQUEZNA TRIPLE PAK 2025-10-31
Labeling
VOQUEZNA DUAL PAK 2025-10-31
Labeling
VOQUEZNA TRIPLE PAK 2025-06-12
Labeling
VOQUEZNA DUAL PAK 2025-06-12
Labeling
VOQUEZNA TRIPLE PAK 2024-07-31
Labeling
VOQUEZNA DUAL PAK 2024-07-31
Labeling
VOQUEZNA 2024-07-17
Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 55%
3 drugs Phase 3: 1 Phase 1: 1
Cardiovascular 31%
1 drugs Phase 3: 1 Phase 2: 1 Phase 1: 1
Dermatology 14%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology, Cardiovascular
COSETTE other
Cardiovascular, Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Dermatology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Cardiovascular